![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Erratum: Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma
Correction to: Bone Marrow Transplantation (2017) 52, 683–688; doi:10.1038/bmt.2016.348; published online 16 January 2017 Since the online publication of this article, it has been noted that the author name JE...
-
Article
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma
We investigated the use of haploidentical hematopoietic stem cell transplantation (haplo-HSCT) in the treatment of advanced Hodgkin lymphoma (HL). Sixty-two consecutive HL patients underwent haplo-HSCT. Unmani...
-
Article
Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation
-
Article
Open AccessESICM LIVES 2016: part two
-
Article
Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis
The outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) patients has significantly improved over the past decade. Still, a significant number of patients require intensive care unit (ICU)...
-
Article
Prognosis of neutropenic patients admitted to the intensive care unit
The prognosis of critically ill cancer patients has improved recently. Controversies remain as regard to the specific prognosis impact of neutropenia in critically ill cancer patients. The primary objective of...